Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.9K
The pathophysiology of pneumonia involves the following steps:
3.9K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

790
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
790
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.1K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C-C Chemokine Receptor 4 Deficiency Protects Against Abdominal Aortic Aneurysm Formation.

Journal of the American Heart Association·2025
Same author

C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice.

eLife·2025
Same author

312 nm UVB Phototherapy Limits Atherosclerosis by Regulating Immunoinflammatory Responses in Mice.

The Kobe journal of medical sciences·2025
Same author

Novel UV-B Phototherapy With a Light-Emitting Diode Device Prevents Atherosclerosis by Augmenting Regulatory T-Cell Responses in Mice.

Journal of the American Heart Association·2024
Same author

The Gut Microbiota Profile in Heart Failure Patients: A Systematic Review.

Journal of gastrointestinal and liver diseases : JGLD·2023
Same author

Depletion of Foxp3<sup>+</sup> regulatory T cells augments CD4<sup>+</sup> T cell immune responses in atherosclerosis-prone hypercholesterolemic mice.

Heliyon·2022

Related Experiment Video

Updated: Mar 18, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.4K

Hepatopulmonary Syndrome: A Brief Review.

Zulkifli Amin, Hilman Zulkifli Amin, Nadim Marchian Tedyanto

    Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
    |June 29, 2016
    PubMed
    Summary

    Hepatopulmonary syndrome (HPS) is a liver disease complication causing low blood oxygen. Lung transplantation can improve quality of life and survival rates for HPS patients despite the condition's poor prognosis.

    Area of Science:

    • Pulmonology
    • Hepatology
    • Transplantation

    Background:

    • Hepatopulmonary syndrome (HPS) is a serious pulmonary complication linked to liver disease.
    • It is characterized by arterial hypoxemia due to diffusion-perfusion imbalances, V/Q mismatch, and arteriovenous shunts.
    • Diagnosis involves identifying liver disease, portal hypertension, elevated alveolar-arterial oxygen gradient, and intrapulmonary vascular dilatations.

    Purpose of the Study:

    • To summarize the key aspects of hepatopulmonary syndrome.
    • To highlight diagnostic criteria and current therapeutic options.
    • To emphasize the role of lung transplantation in managing HPS.

    Main Methods:

    • Literature review of hepatopulmonary syndrome.
    • Analysis of diagnostic markers for HPS.

    More Related Videos

    Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
    07:11

    Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

    Published on: May 23, 2025

    1.1K
    Experimental Model to Evaluate Resolution of Pneumonia
    09:49

    Experimental Model to Evaluate Resolution of Pneumonia

    Published on: February 17, 2023

    2.0K

    Related Experiment Videos

    Last Updated: Mar 18, 2026

    The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
    07:29

    The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

    Published on: March 8, 2019

    11.4K
    Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
    07:11

    Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

    Published on: May 23, 2025

    1.1K
    Experimental Model to Evaluate Resolution of Pneumonia
    09:49

    Experimental Model to Evaluate Resolution of Pneumonia

    Published on: February 17, 2023

    2.0K
  • Evaluation of treatment outcomes, focusing on lung transplantation.

    • Main Results:

    • HPS involves complex physiological abnormalities leading to hypoxemia.
    • Diagnosis relies on a combination of clinical, physiological, and imaging findings.
    • Lung transplantation is the most effective treatment, improving patient outcomes.

    Conclusions:

    • Hepatopulmonary syndrome presents significant challenges in liver disease patients.
    • Early diagnosis and appropriate management, particularly lung transplantation, are crucial.
    • Despite a poor prognosis, interventions can enhance quality of life and survival.